J
Johnson Pharmacare Ltd
BSE:532154
Johnson Pharmacare Ltd
BSE:532154
Price:
0.54
INR
-3.57%
Market Closed
Market Cap:
₹297m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
J
|
Johnson Pharmacare Ltd
BSE:532154
|
IN |
|
Glory Flame Holdings Ltd
HKEX:8059
|
HK |
|
S
|
Solteq Oyj
OMXH:SOLTEQ
|
FI |
|
AK Medical Holdings Ltd
HKEX:1789
|
CN |
Income Statement
Earnings Waterfall
Johnson Pharmacare Ltd
Johnson Pharmacare Ltd
Income Statement
Johnson Pharmacare Ltd
Johnson Pharmacare Ltd
Currency: INR
| Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||
| Revenue |
33
N/A
|
43
+29%
|
25
-41%
|
25
N/A
|
25
+0%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Gross Profit | ||||||||||||
| Cost of Revenue |
(27)
|
(35)
|
(20)
|
(20)
|
(20)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gross Profit |
6
N/A
|
8
+32%
|
5
-36%
|
5
N/A
|
5
+0%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||||
| Operating Expenses |
(4)
|
(5)
|
(5)
|
(5)
|
(3)
|
(0)
|
(0)
|
(3)
|
(6)
|
(6)
|
(6)
|
|
| Selling, General & Administrative |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Operating Expenses |
(3)
|
(4)
|
(4)
|
(4)
|
(2)
|
(0)
|
(0)
|
(2)
|
(6)
|
(6)
|
(6)
|
|
| Operating Income |
1
N/A
|
3
+214%
|
(0)
N/A
|
(0)
+55%
|
2
N/A
|
(0)
N/A
|
(0)
-3 738%
|
(3)
-716%
|
(6)
-139%
|
(6)
0%
|
(6)
+1%
|
|
| Pre-Tax Income | ||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
(16)
|
0
|
0
|
(3)
|
0
|
0
|
(0)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
(15)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
1
N/A
|
3
+214%
|
0
-100%
|
(15)
N/A
|
(13)
+13%
|
(0)
+100%
|
(0)
-3 738%
|
(6)
-1 802%
|
(6)
-2%
|
(6)
0%
|
(6)
-6%
|
|
| Net Income | ||||||||||||
| Tax Provision |
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
1
|
3
|
(0)
|
(16)
|
(13)
|
(0)
|
(0)
|
(6)
|
(6)
|
(6)
|
(6)
|
|
| Net Income (Common) |
1
N/A
|
3
+176%
|
(0)
N/A
|
(16)
-4 090%
|
(13)
+18%
|
(0)
+100%
|
(0)
-3 738%
|
(6)
-1 802%
|
(6)
-2%
|
(6)
0%
|
(6)
-6%
|
|
| EPS (Diluted) |
0
N/A
|
0.01
N/A
|
0
N/A
|
-0.03
N/A
|
-0.02
+33%
|
0
N/A
|
0
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
